BioSpace News Archive

Xenocor, Inc. announced the FDA cleared the new Xenocor Disposable 5mm Articulating Laparoscope for minimally invasive abdominal and thoracic surgery. The Xenoscope 5mm articulating disposable laparoscope is designed to improve image quality, reduce fog, lower hospital costs, and reduce bio-hazard risk for the patient and staff.

Continues progress toward antitrust clearance for Bayer AG’s animal health business

The American Pharmacists Association applauds a new program in Ohio announced between UnitedHealthcare Community Health Plan and two community pharmacies.

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates

Meridian Bioscience, Inc. (NASDAQ: VIVO), announced today the launch of several novel recombinant antigens critical for the development of antibody tests for COVID-19. Since the emergence of COVID-19 outbreaks in January, Meridian has supported molecular diagnostic companies with critical master mixes and enzymes for their COVID-19 Molecular Diagnostics tests. To meet the massive need for antibody testing, Meridian has now launched a series of

Women with Polycystic Ovary Syndrome (PCOS) should consider adopting a mindful yoga practice to help ease symptoms and improve androgen levels.

Amedisys, Inc. (NASDAQ: AMED), announced today that it will report results for the first quarter ended March 31, 2020, after the market closes on May 6, 2020. The Company will host an investor conference call to discuss these results at 11:00 a.m. ET on May 7, 2020. To participate on the conference call, please call a few minutes before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412) 902-1028 (Toll). A replay of the conference

Chromatic Technologies Inc. (CTI) has partnered with American Thermal Instruments (ATI) in Dayton, Ohio, to donate free-of-charge new printable temperature, tampering and authentication technology to protect all new COVID-19 drugs.

Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic patient care services and solutions, today announced it will report its financial results for the first quarter ended March 31, 2020 after the stock market closes on Thursday, May 7, 2020. Hanger’s management team will host a conference call with the financial community to discuss the financial results the following morning on Friday, May 8 at 8

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases, today announced positive top-line Phase 1 clinical trial results for ADX-629, a first-in-class orally available reactive aldehyde species (RASP) inhibitor in development for the treatment of systemic i